Prasol Chemicals Limited (NSE:PRASOLCHEM)
India · Delayed Price · Currency is INR 773.00
-13.65 (-1.74%)
Nov 9, 2026, 3:29 PM IST
Prasol Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '21 Mar 31, 2021 |
Operating Revenue | 14,605 | 12,326 | 10,125 | 8,766 | 9,301 | 5,955 |
Other Revenue | 57.6 | 35.12 | 25.55 | 14.49 | 12.27 | - |
| 14,663 | 12,361 | 10,150 | 8,780 | 9,313 | 5,955 | |
Revenue Growth | - | 21.78% | 15.61% | -5.72% | 56.38% | 12.10% |
Cost of Revenue | 9,863 | 8,673 | 7,337 | 6,552 | 6,569 | 4,380 |
Gross Profit | 4,799 | 3,688 | 2,814 | 2,228 | 2,744 | 1,576 |
Selling, General & Admin | 610.11 | 546.07 | 451.02 | 358.13 | 323.1 | 189.56 |
Other Operating Expenses | 1,938 | 1,666 | 1,427 | 1,236 | 1,526 | 864.52 |
Operating Expenses | 2,808 | 2,458 | 2,110 | 1,807 | 2,041 | 1,181 |
Operating Income | 1,991 | 1,230 | 704.14 | 421.2 | 703.2 | 394.77 |
Interest Expense | -61.88 | -74.73 | -73.89 | -102.2 | -111.73 | -105.21 |
Interest & Investment Income | 1.8 | 1.8 | 0.49 | 12.1 | 1.83 | 0.98 |
Earnings From Equity Investments | - | - | - | -0.12 | - | - |
Currency Exchange Gain (Loss) | -37.7 | -37.7 | -37.1 | 61.35 | -12.97 | 58.59 |
Other Non Operating Income (Expenses) | 8.49 | 8.49 | -0.79 | -4.68 | 0.03 | -5.89 |
EBT Excluding Unusual Items | 1,902 | 1,127 | 592.85 | 387.65 | 580.36 | 343.24 |
Gain (Loss) on Sale of Assets | -10.65 | -10.65 | -0.41 | -14.93 | 1.46 | -5.95 |
Other Unusual Items | - | - | - | -57.64 | - | - |
Pretax Income | 1,894 | 1,119 | 592.87 | 335.1 | 582.73 | 337.9 |
Income Tax Expense | 486.81 | 287.75 | 157.18 | 153.79 | 96.85 | 87.06 |
Earnings From Continuing Operations | 1,407 | 831.24 | 435.69 | 181.31 | 485.88 | 250.84 |
Net Income | 1,407 | 831.24 | 435.69 | 181.31 | 485.88 | 250.84 |
Net Income to Common | 1,407 | 831.24 | 435.69 | 181.31 | 485.88 | 250.84 |
Net Income Growth | - | 90.79% | 140.30% | -62.68% | 93.70% | -33.60% |
Shares Outstanding (Basic) | 58 | 58 | 58 | 58 | 58 | 58 |
Shares Outstanding (Diluted) | 58 | 58 | 58 | 58 | 58 | 58 |
Shares Change | 0.13% | - | - | - | - | - |
EPS (Basic) | 24.22 | 14.33 | 7.51 | 3.13 | 8.38 | 4.32 |
EPS (Diluted) | 24.22 | 14.33 | 7.51 | 3.13 | 8.38 | 4.32 |
EPS Growth | - | 90.81% | 140.24% | -62.68% | 93.70% | -33.60% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '21 Mar 31, 2021 |
Free Cash Flow | -285.19 | 104.71 | -3.22 | 964.68 | -238.3 | -270.51 |
Free Cash Flow Per Share | -4.91 | 1.80 | -0.06 | 16.63 | -4.11 | -4.66 |
Dividend Per Share | - | 1.200 | 0.300 | 0.300 | 0.300 | 0.075 |
Dividend Growth | - | 300.00% | 0% | 0% | 300.00% | 0% |
Gross Margin | 32.73% | 29.83% | 27.72% | 25.38% | 29.46% | 26.46% |
Operating Margin | 13.58% | 9.95% | 6.94% | 4.80% | 7.55% | 6.63% |
Profit Margin | 9.59% | 6.73% | 4.29% | 2.07% | 5.22% | 4.21% |
Free Cash Flow Margin | -1.94% | 0.85% | -0.03% | 10.99% | -2.56% | -4.54% |
EBITDA | 2,251 | 1,475 | 936.15 | 634.07 | 893.88 | 517.01 |
EBITDA Margin | 15.35% | 11.94% | 9.22% | 7.22% | 9.60% | 8.68% |
D&A For EBITDA | 259.69 | 245.88 | 232.01 | 212.87 | 190.68 | 122.24 |
EBIT | 1,991 | 1,230 | 704.14 | 421.2 | 703.2 | 394.77 |
EBIT Margin | 13.58% | 9.95% | 6.94% | 4.80% | 7.55% | 6.63% |
Effective Tax Rate | 25.71% | 25.71% | 26.51% | 45.89% | 16.62% | 25.77% |
Revenue as Reported | 14,680 | 12,378 | 10,155 | 8,876 | 9,326 | 6,021 |
Advertising Expenses | - | 40.43 | 32.39 | 28.12 | 22.12 | 0.62 |